News

Barbie-parent Mattel pulls annual forecasts, to hike prices as tariffs raise costs
"Given the volatile macroeconomic environment and evolving U.S. tariff landscape, it is difficult to predict consumer ...
TMCnet5d
CD8 Technology Signs Letter of Intent for Tevogen Bio's In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of ...